Treatment of acne and acne-related scarring with fixed combination clindamycin phosphate and benzoyl peroxide gel (1.2%/3.75%) and tretinoin gel microsphere 0.06% in an Asian American transgender female

SAGE Open Med Case Rep. 2020 Dec 29:8:2050313X20984038. doi: 10.1177/2050313X20984038. eCollection 2020.

Abstract

Acne vulgaris is one of the most common skin diseases in the United States and can affect any gender or ethnic group. Post-inflammatory hyperpigmentation (PIH) and scarring from acne can have a negative psychosocial impact on patients. Skin of color patients are particularly prone to PIH, as the dark marks left from acne may take several months to resolve, far after the acne has cleared. Here, we report a case of moderate acne with associated scarring in a transgender, Asian American female who was successfully treated with fixed combination topical therapy with clindamycin phosphate and benzoyl peroxide gel 1.2%/3.75% and tretinoin gel microsphere 0.06%.

Keywords: Acne vulgaris; acne-related scarring; benzoyl peroxide; clindamycin; estrogens; hormone therapy; hyperpigmentation; skin of color; transgender dermatology; tretinoin.

Publication types

  • Case Reports